3
Announcements
Trials
Browse
Landscape
Status
Recruiting
5
Terminated
4
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
9
Myelodysplastic Syndromes
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Burkitt Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Smoldering Multiple Myeloma
1
Primary Myelofibrosis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia
1
Bone Marrow Neoplasms
1
Interventions
ruxolitinib
9
navitoclax
4
Tacrolimus
4
Cyclophosphamide
4
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
venetoclax
2
fludarabine phosphate
2
fludarabine
2
Melphalan
2
Busulfan
2
veliparib
1
selinexor
1
pevonedistat
1
luspatercept
1
letermovir
1
itacitinib
1
imetelstat
1
givinostat hydrochloride
1
givinostat
1
fedratinib
1
elotuzumab
1
canakinumab
1
avelumab
1
Valganciclovir
1
Topotecan
1
Therapeutics
1
Stem Cell Transplantation
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Primary Myelofibrosis
×
Stem Cell Transplantation
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled